Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.335
-0.015 (-1.11%)
Aug 18, 2025, 3:16 PM - Market open
Evogene Market Cap
Evogene has a market cap or net worth of $11.61 million as of August 18, 2025. Its market cap has decreased by -56.98% in one year.
Market Cap
11.61M
Enterprise Value
21.29M
1-Year Change
-56.98%
Ranking
Category
Stock Price
$1.34
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $11.61M, a decrease of -58.55%. That is a compound annual growth rate of -4.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2025 | 11.61M | -10.69% |
| Dec 31, 2024 | 13.00M | -69.10% |
| Dec 31, 2023 | 42.08M | 60.85% |
| Dec 29, 2022 | 26.16M | -63.27% |
| Dec 30, 2021 | 71.23M | -58.31% |
| Dec 31, 2020 | 170.86M | 335.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 629.52B |
| Johnson & Johnson | 425.41B |
| AbbVie | 365.13B |
| UnitedHealth Group | 275.33B |
| AstraZeneca | 243.89B |
| Novartis AG | 239.15B |
| Abbott Laboratories | 229.31B |
| Novo Nordisk | 227.24B |